D304N (p.Asp304Asn) variant of BEST1 (Bestrophin-1)

D304N (p.Asp304Asn) in BEST1 (Bestrophin-1) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of Vitelliform macular dystrophy 2. The available variant effect predictions contribute to a CATVariant prioritization score of 0.94 / 1. The record also includes published literature and structural context.

D304N (p.Asp304Asn) variant details